All studies
Not yet recruitingOBSERVATIONAL

Calibration of AlgoRithm for Detection of Cardiac Decompensation Via Parametric Objects (CARDCOP)

This study, called CARDCOP, is looking to make an AI tool called TakeCoeur even better. This tool is designed to help detect early signs of worsening heart failure by using information collected from everyday smart devices like smartwatches, blood pressure monitors, and smart scales. Many people in the UK live with heart failure, and sometimes their condition can suddenly get worse, leading to hospital visits. By spotting these changes early, doctors can provide help sooner, which might prevent hospital stays and improve how people with heart failure live. This research helps fine-tune the AI so it can accurately recognise these important health changes.

At a glance

Status
Not yet recruiting
Sponsor
University Hospital, Brest
Enrolment target
640
Start
01 Nov 2024
Estimated completion
01 May 2026

What is this study about?

Heart failure is a condition where your heart doesn't pump blood as effectively as it should. This can lead to symptoms like breathlessness, swelling, and tiredness. For many people, heart failure is a long-term condition that can sometimes get worse quite suddenly, which doctors call 'decompensation'. When this happens, it often means a trip to the hospital.

This study, called CARDCOP (Calibration of AlgoRithm for Detection of Cardiac Decompensation Via Parametric Objects), is focused on making a new AI (Artificial Intelligence) tool, named TakeCoeur, more accurate. This tool is designed to act like an early warning system. It works by collecting information about your health – things like your weight, blood pressure, and heart rate – from smart devices you might wear or use at home, like a smartwatch, a blood pressure monitor, and a smart scale. The main goal is to teach the AI to recognise patterns in this information that suggest your heart failure might be getting worse, even before you feel very unwell.

By improving how well this AI tool works, doctors hope to be able to step in earlier when someone's heart failure is worsening. This could mean adjusting medication, giving advice, or arranging a check-up before the condition becomes severe enough to require hospital care. Ultimately, the aim is to help people with heart failure stay healthier and out of hospital, improving their quality of life.

Key takeaways

  • The study is about improving an AI tool for early detection of worsening heart failure.
  • It uses data from everyday smart devices like watches and scales.
  • The goal is to help prevent hospital stays for people with heart failure.
  • Participation involves sharing physiological data via connected devices.
  • This research aims to eventually improve the quality of life for heart failure patients.

Who may be eligible?

This study is looking for adults aged 18 or over who have been diagnosed with ongoing (chronic) heart failure by a heart specialist. To join, participants must have either been in hospital for their heart failure in the last year, or have a certain level of heart failure symptoms (classified as NYHA Class II to IV) along with specific blood test results.

There are also some reasons why people cannot join. For example, if you are having kidney dialysis, are waiting for a heart transplant, have a very high body weight (severe obesity), or a very specific type of heart valve problem that can't be fixed by surgery. You also can't join if you have another serious illness that limits your life expectancy to less than a year, or if you already use a similar remote monitoring device. It's also important that you (or someone helping you) can use a smartphone, tablet, or computer to connect the devices and share information, and that you are able to wear a smartwatch for the study's duration.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 18 years old or older?
  2. Have you been diagnosed with ongoing heart failure by a heart specialist?
  3. Have you been in hospital for your heart failure in the last year, or do you have certain heart failure symptoms and specific blood test results?
  4. Can you (or someone helping you) use a smartphone/tablet/computer with internet?
  5. Are you able to wear a smartwatch for the study's duration?
Answer every question to see your result.

What does participation involve?

The study doesn't specify details about visits or follow-up, but it involves using connected medical devices like a smartwatch, blood pressure monitor, and a smart scale. These devices will actively and passively collect your physiological data, such as your weight, blood pressure, and heart rate. You will need to be able to use a smartphone, computer, or tablet to help transmit this data. The study doesn't mention specific medications or a total duration of participation.

Potential risks and benefits

This study aims to make an AI tool better at spotting early signs of worsening heart failure, which might eventually help a lot of people avoid hospital stays. The main benefit is contributing to this important research. As this study mainly involves using smart devices to collect health information, there are likely minimal direct risks, but you would be regularly sharing personal health data. You are free to stop taking part in the study at any time without giving a reason.

Locations (3)

  • Chu Brest
    Verified postcode
    Brest, France
  • CH Morlaix
    Verified postcode
    Morlaix, France
  • CH Vannes
    Verified postcode
    Vannes, France

Common questions

What is the TakeCoeur AI device?

It's an Artificial Intelligence tool designed to detect early signs that heart failure might be getting worse, using data from smart health devices.

What kind of information will be collected from me?

The study will collect information like your weight, blood pressure, and heart rate from devices such as a smartwatch, blood pressure monitor, and smart scale.

Will I have to go to the hospital often for this study?

The study description doesn't mention frequent hospital visits. It focuses on collecting data remotely using smart devices.

What does 'heart failure decompensation' mean?

It means your heart failure symptoms are suddenly getting worse and your heart is struggling more than usual.

Can I still take my regular heart failure medication?

The study brief doesn't mention changes to your regular medication, but you should discuss all your treatments with the study team.

How to find out more

Jacques MANSOURATI

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Calibration of AlgoRithm for Detection of Cardiac Decompensa…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.